Nihal Farid Younes

Dr. Nihal Farid Younes

Department of Pharmaceutics and industrial pharmacy, Faculty of Pharmacy, Cairo University
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2018 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
NYNihal Farid Younes
Nihal Farid Younes
SASally Adel Abdel-Halim
Sally Adel Abdel-Halim
AEAbdelhalim I. Elassasy
Abdelhalim I. Elassasy

1 January 2018 in Drug Delivery
Verified
Journal Article
Open access
NYNihal Farid Younes
Nihal Farid Younes
SASally Adel Abdel-Halim
Sally Adel Abdel-Halim
AEAbdelhalim I. Elassasy
Abdelhalim I. Elassasy
Keratomycosis is a serious corneal disease that can cause a permanent visual disability if not treated effectively. Sertaconazole nitrate (STZ), a novel broad spectrum antifungal drug, was suggested as a promising treatment. However, its utility in the ocular route is restricted by its poor solubility, along with other problems facing the ocular delivery like short residence time, and the existing corneal barrier. Therefore, the objective of this study was to formulate STZ loaded binary mixed micelles (STZ-MMs) enriched with different penetration enhancers using thin-film hydration method, based on a 31.22 mixed factorial design. Different formulation variables were examined, namely, type of auxiliary surfactant, type of penetration enhancer, and total surfactants: drug ratio, and their effects on the solubility of STZ in MMs (SM), particle size (PS), polydispersity index (PDI), and zeta potential (ZP) were evaluated. STZ-MMs enhanced STZ aqueous solubility up to 338.82-fold compared to free STZ. Two optimized formulations (MM-8 and MM-11) based on the desirability factor (0.891 and 0.866) were selected by Design expert® software for further investigations. The optimized formulations were imaged by TEM which revealed nanosized spherical micelles. Moreover, they were examined for corneal mucoadhesion, stability upon dilution, storage effect, and ex vivo corneal permeation studies. Finally, both in vivo corneal uptake and in vivo corneal tolerance were investigated. MM-8 showed superiority in the ex vivo and in vivo permeation studies when compared to the STZ-suspension. The obtained results suggest that the aforementioned STZ loaded mixed micellar system could be an effective candidate for Keratomycosis-targeted therapy.

5 January 2023 in Drug Delivery
Verified
Journal Article
Open access
HEHeba Amin Elgendy
Heba Amin Elgendy
AMAmna M. A. Makky
Amna M. A. Makky
YEYara E. Elakkad
Yara E. Elakkad
RIRadwa M. Ismail
Radwa M. Ismail
NYNihal Farid Younes
Nihal Farid Younes
Atorvastatin calcium (ATV) is a well-known anti-hyperlipidemic drug currently being recognized for possessing an anti-inflammatory effect. Introducing it as a novel remedy for periodontitis treatment necessitates developing a syringeable modified delivery system capable of targeting inflammation within the periodontal pockets. Thus, a 33 Box-Behnken design was used to generate eugenol enriched PEGylated cubosomes. Based on the desirability function, the optimized formulation (OEEPC) was selected exhibiting a solubilization efficiency (SE%) of 97.71 ± 0.49%, particle size (PS) of 135.20 ± 1.11 nm, polydispersity index (PDI) of 0.09 ± 0.006, zeta potential (ZP) of −28.30 ± 1.84 mV and showing a sustained drug release over 12 h. It displayed a cubic structure under the transmission electron microscope, furthermore, it was stable upon storage for up to 30 days. Hence, it was loaded into an optimum syringeable in-situ gel (ISG) which displayed the desired periodontal gelation temperature (34 ± 0.70 °C) and an adequate gelation time (46 ± 2.82 sec), it also released approximately 75% of the drug within 72 h. Clinical evaluation of the ISG showed a promising percentage reduction of about 58.33% in probing depth, 90% in the bleeding index, 81.81% in the plaque index, and 70.21% in gingival levels of transforming growth factor–β1. This proved that the formulated syringeable intra-pocket delivery system of ATV is an efficient candidate for diminishing inflammation in periodontitis. Graphical Abstract

20 February 2024 in Journal of Pharmaceutical Investigation
Verified
Journal Article
Open access
PDF file
HEHeba Amin Elgendy
Heba Amin Elgendy
AMAmna M. A. Makky
Amna M. A. Makky
YEYara E. Elakkad
Yara E. Elakkad
HAHeba Hossameldin Awad
Heba Hossameldin Awad
MHMahmoud El Hassab
Mahmoud El Hassab
NYNihal Farid Younes
Nihal Farid Younes
Purpose: Up-to-date literature offers limited data about utilizing atorvastatin calcium (ATV) as a promising chondroprotective agent in osteoarthritis (OA). So, this study aims to develop a depot intra-articular (IA) delivery system for ATV to enhance its deposition in the articular joint. Methods: A 33 D-optimal design was implemented to prepare ATV-loaded lecithin-coated zein nanoparticles. The optimized formulation (Opt-LCZN) was selected and imaged using a transmission electron microscope according to the desirability value. Various in-vitro and in-silico studies were conducted to evaluate the features of Opt-LCZN. Additionally, it was loaded into an injectable thermogel (Opt-LCZN-thermogel) and evaluated in-vivo in OA-induced Sprague Dawley rats. Results: The Opt-LCZN showed entrapment efficiency of 70.00 ± 2.96%, particle size of 191.95 ± 17.42 nm, zeta potential of − 20.12 ± 0.79 mV, and polydispersity index of 0.25 ± 0.01. The docking studies revealed favorable binding of zein and ATV, confirmed by molecular dynamics simulation. The morphological examination displayed a bilayer spherical structure formed of a zein core enclosed by a lecithin coat. Furthermore, the formulated Opt-LCZN-thermogel achieved a remarkable sustained release profile, with nearly 50% of the drug being released over 144 h. Opt-LCZN-thermogel showed a significant reduction in inflammation in OA-induced rats, confirmed by knee joint swelling and knee bend test results, in addition to the pro-inflammatory and anti-inflammatory mediators’ levels. The protective effect of ATV can be markedly observed through histopathological examination. Conclusion: Based on these outcomes, the formulated IA delivery system of ATV can be presented as an excellent candidate for ameliorating OA. Graphical


30 April 2024 in Journal of Drug Delivery Science and Technology
Verified
Journal Article
Closed access
NYNihal Farid Younes
Nihal Farid Younes
SSSinar Sayed
Sinar Sayed
MHMariam Hassan
Mariam Hassan
SASadek Ahmed
Sadek Ahmed